Scientific Session

In Advanced OA, Is Further Conservative Treatment Such as Bracing or Physical Therapy Effective Before THA/TKA or Just Introducing Delays to Surgery?

Speaker(s)

• 

  Jasvinder Singh, MD, MPH

  University of Alabama at Birmingham
  Birmingham, AL, United States

  Disclosure: Disclosure(s): Adaptimmune Therapeutics: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Adept Field Solutions: Consultant (Ongoing); Amarin: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); American College of Rheumatology: Consultant (Ongoing), Officer or Board Member (Ongoing); Atyu Biopharma: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Charlotte's Web Holdings, Inc.: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Clearview Healthcare Partners: Consultant (Ongoing); Clinical Care Options: Consultant (Ongoing); Crealta/Horizon: Consultant (Ongoing); Enzolytics Inc.: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); FDA Arthritis Advisory Committee: Advisor or Review Panel Member (Ongoing); Fidia: Consultant (Ongoing); Focus Forward: Consultant (Ongoing); GeoVax Labs: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Intuitive Surgical Inc./Philips Electronics North America: food and beverage payment (Ongoing); Jupiter Life Science: Consultant (Ongoing); MedIQ: Consultant (Ongoing); Medisys: Consultant (Ongoing); Medscape: Consultant (Ongoing); Moderna Pharmaceuticals: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); National Institutes of Health: Consultant (Ongoing); Navigant Consulting: Consultant (Ongoing); Outcomes Measures in Rheumatology (OMERACT): Officer or Board Member (Ongoing); Pieris Pharmaceuticals: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); PK Med: Consultant (Ongoing); Practice Point Communications: Consultant (Ongoing); Putnam Associates: Consultant (Ongoing); Schipher: Consultant (Ongoing); Seres Therapeutics: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Simply Speaking: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Spherix: Consultant (Ongoing); Tonix Pharmaceuticals Holding Corp: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); TPT Global Tech: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Trio Health: Consultant (Ongoing); Two Labs Inc.: Consultant (Ongoing); UBM LLC: Consultant (Ongoing); University of Alabama at Birmingham (UAB) Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis: editor and director (Ongoing); Vaxart Pharmaceuticals: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Veterans Affairs Rheumatology Field Advisory Board (FAB): Officer or Board Member (Ongoing); Viking: Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); WebMD: Consultant (Ongoing); Zimmer Biomet Holdings: Grant/Research Support (Ongoing)